[Pyrimidine- and purine-type antimetabolites].
D000963:Antimetabolites / Q000627:therapeutic use*; D005493:Folic Acid Antagonists / Q000627:therapeutic use; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy*; D011687:Purines / Q000378:metabolism*; D011743:Pyrimidines / Q000378:metabolism*
D000963:Antimetabolites; D005493:Folic Acid Antagonists; D011687:Purines; D011743:Pyrimidines
Antimetabolity pyrimidinového a purinového typu.